- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 18, 2025 | 98.63M sh |
| Long Term Debt | Q1 2025 · Mar 30, 2025 | $4.98B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.99B |
| Short Term Debt | Q1 2025 · Mar 30, 2025 | $2.15B |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.05B |
| Cash And Equivalents | Q1 2025 · Mar 30, 2025 | $181.83M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $431.01M |
| Stockholders Equity | Q1 2025 · Mar 30, 2025 | $2.45B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.27B |
| Current Liabilities | Q1 2025 · Mar 30, 2025 | $3.99B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.04B |
| Total Liabilities | Q1 2025 · Mar 30, 2025 | $10.22B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.22B |
| Current Assets | Q1 2025 · Mar 30, 2025 | $3.17B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.18B |
| Total Assets | Q1 2025 · Mar 30, 2025 | $12.68B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.51B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 99.16M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $9.14M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $50.14M |
| Capex | Q1 2025 · Mar 31, 2024 | $86.46M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $166.24M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.66 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.66 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $167.58M |
| Net Income | Q1 2025 · Mar 31, 2024 | $65.18M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $72.57M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $271.17M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $1.04B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $1.31B |